Average cost of multi drug-resistant tuberculosis treatment in Mali
Mali: Average cost of multi drug-resistant tuberculosis treatment was 709 constant 2022 US$ in 2024. ◆ Volatile
Average cost of multi drug-resistant tuberculosis treatment in Mali, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
The most recent figure for average cost of multi drug-resistant tuberculosis treatment in Mali is 709 constant 2022 US$, measured in 2024. That is the lowest value across all 7 years on record.
Compared with earlier readings it is down 67.8% on the previous year and down 82.6% over ten years.
That places Mali 67th out of 92 countries with data for 2024, putting it in the middle of the range.
Average cost of multi drug-resistant tuberculosis treatment in Mali, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 4,085 constant 2022 US$ | — |
| 2018 | 3,636 constant 2022 US$ | -11.0% |
| 2019 | 8,674 constant 2022 US$ | +138.6% |
| 2020 | 4,576 constant 2022 US$ | -47.2% |
| 2021 | 65,208 constant 2022 US$ | +1325.0% |
| 2023 | 2,200 constant 2022 US$ | -96.6% |
| 2024 | 709 constant 2022 US$ | -67.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 5,465 constant 2022 US$ | 3,636 constant 2022 US$ | 8,674 constant 2022 US$ | 3 |
| 2020s | 18,173 constant 2022 US$ | 709 constant 2022 US$ | 65,208 constant 2022 US$ | 4 |
Countries ranked near Mali
- 64 Lao People's Democratic Republic 756 constant 2022 US$ compare
- 65 Bolivia, Plurinational State of 753 constant 2022 US$ compare
- 66 Congo 726 constant 2022 US$ compare
- 68 Fiji 700 constant 2022 US$ compare
- 69 South Sudan 682 constant 2022 US$ compare
- 70 Venezuela, Bolivarian Republic of 674 constant 2022 US$ compare
More health data for Mali
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.18 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 878 deaths per 1,000 people (2090)
- Number of infants who die before age 1 24,194 deaths (2100)
- Population ages 0-14, female, annual growth rate 2.19 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.2265 units per person (2025)
- Population ages 0-14, male, annual growth rate 2.14 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.2314 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Mali?
- Average cost of multi drug-resistant tuberculosis treatment in Mali was 709 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Mali?
- The highest recorded value was 65,208 constant 2022 US$ in 2021.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Mali?
- The lowest recorded value was 709 constant 2022 US$ in 2024.
- How does Mali rank for average cost of multi drug-resistant tuberculosis treatment?
- Mali ranks 67th out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Mali?
- Over the last ten years it is down 82.6%. The long-run trend across the full record is volatile.
- Where does this Mali data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.